These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21537678)

  • 1. An experimental protocol for the establishment of dogs with long-term cellular immune reactions to Leishmania antigens.
    Teixeira MC; Oliveira GG; Santos PO; Bahiense TC; da Silva VM; Rodrigues MS; Larangeira DF; Dos-Santos WL; Pontes-de-Carvalho LC
    Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):182-9. PubMed ID: 21537678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.
    Petitdidier E; Pagniez J; Papierok G; Vincendeau P; Lemesre JL; Bras-Gonçalves R
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004614. PubMed ID: 27223609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
    Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
    Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine Leishmania vaccines: still a long way to go.
    Gradoni L
    Vet Parasitol; 2015 Feb; 208(1-2):94-100. PubMed ID: 25620293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
    Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum.
    Rhalem A; Sahibi H; Guessous-Idrissi N; Lasri S; Natami A; Riyad M; Berrag B
    Vet Parasitol; 1999 Mar; 81(3):173-84. PubMed ID: 10190861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis.
    Leandro C; Santos-Gomes GM; Campino L; Romão P; Cortes S; Rolão N; Gomes-Pereira S; Riça Capela MJ; Abranches P
    Vet Immunol Immunopathol; 2001 May; 79(3-4):273-84. PubMed ID: 11389961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis.
    Nieto CG; García-Alonso M; Requena JM; Mirón C; Soto M; Alonso C; Navarrete I
    Vet Immunol Immunopathol; 1999 Feb; 67(2):117-30. PubMed ID: 10077418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts.
    Coelho EA; Ramírez L; Costa MA; Coelho VT; Martins VT; Chávez-Fumagalli MA; Oliveira DM; Tavares CA; Bonay P; Nieto CG; Abánades DR; Alonso C; Soto M
    Clin Vaccine Immunol; 2009 Dec; 16(12):1774-80. PubMed ID: 19812259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of immune responses in dogs with canine visceral leishmaniasis before, and after, drug treatment.
    Rhalem A; Sahibi H; Lasri S; Jaffe CL
    Vet Immunol Immunopathol; 1999 Oct; 71(1):69-76. PubMed ID: 10522787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis.
    Carrillo E; Ahmed S; Goldsmith-Pestana K; Nieto J; Osorio Y; Travi B; Moreno J; McMahon-Pratt D
    Vaccine; 2007 Feb; 25(8):1534-43. PubMed ID: 17178178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis.
    Martínez-Moreno A; Moreno T; Martínez-Moreno FJ; Acosta I; Hernández S
    Vet Immunol Immunopathol; 1995 Oct; 48(3-4):209-20. PubMed ID: 8578681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum.
    Bras-Gonçalves R; Petitdidier E; Pagniez J; Veyrier R; Cibrelus P; Cavaleyra M; Maquaire S; Moreaux J; Lemesre JL
    Infect Genet Evol; 2014 Jun; 24():1-14. PubMed ID: 24614507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected population.
    Nakhaee A; Taheri T; Taghikhani M; Mohebali M; Salmanian AH; Fasel N; Rafati S
    Vet Parasitol; 2004 Jan; 119(2-3):107-23. PubMed ID: 14746971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum.
    Pinelli E; Killick-Kendrick R; Wagenaar J; Bernadina W; del Real G; Ruitenberg J
    Infect Immun; 1994 Jan; 62(1):229-35. PubMed ID: 8262632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed analysis of an experimental challenge model for Leishmania infantum (JPC strain) in dogs.
    Poot J; Rogers ME; Bates PA; Vermeulen A
    Vet Parasitol; 2005 Jun; 130(1-2):41-53. PubMed ID: 15893068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.
    Schaut RG; Grinnage-Pulley TL; Esch KJ; Toepp AJ; Duthie MS; Howard RF; Reed SG; Petersen CA
    Vaccine; 2016 Oct; 34(44):5225-5234. PubMed ID: 27665354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
    Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
    Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry.
    Silvestre R; Santarém N; Cunha J; Cardoso L; Nieto J; Carrillo E; Moreno J; Cordeiro-da-Silva A
    Vet Parasitol; 2008 Nov; 158(1-2):23-30. PubMed ID: 18848397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.